Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health Selected as a Limited Distribution Provider of VILTEPSO™ (viltolarsen) Injection for Patients with Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
BANNOCKBURN, Ill. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has been selected to participate in the limited distribution network of VILTEPSO™
Toggle Summary Option Care Health to Participate in Upcoming Virtual Investor Conferences
BANNOCKBURN, Ill. , Aug. 27, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Baird 2020
Toggle Summary Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference
BANNOCKBURN, Ill. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the 40 th Annual Canaccord Genuity Virtual Growth Conference on
Toggle Summary Option Care Health Announces Financial Results for the Second Quarter
BANNOCKBURN, Ill. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30,
Toggle Summary Option Care Health Announces Pricing of Offering of 18,000,000 Shares of Common Stock
BANNOCKBURN, Ill. , July 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“ Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today the pricing of an underwritten offering of 18,000,000 shares of its common stock, which includes 10,000,000 shares offered by the Company
Toggle Summary Option Care Health Announces Proposed Offering of $350 Million of Shares of Common Stock
BANNOCKBURN, Ill. , July 20, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“ Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today a proposed underwritten offering of $350 million of shares of its common stock, which includes $125 million of shares offered by the Company and
Toggle Summary Option Care Health Announces Preliminary Financial Results for the Second Quarter and Schedules Second Quarter Earnings Call
BANNOCKBURN, Ill. , July 20, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary financial results for the second quarter ended
Toggle Summary Option Care Health to Participate in the William Blair Virtual Growth Stock Conference
BANNOCKBURN, Ill. , May 28, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the William Blair Virtual Growth Stock Conference on Thursday, June
Toggle Summary Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy
First surgery-free treatment option for rare, difficult-to-treat urinary tract cancer requires complex clinical protocol BANNOCKBURN, Ill. , May 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent provider
Toggle Summary Option Care Health Announces Financial Results for the First Quarter and Provides an Update on the Impact of COVID-19 Pandemic
BANNOCKBURN, Ill. , May 07, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2020